Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Neurogenetics. 2009 Aug 4;11(1):139–142. doi: 10.1007/s10048-009-0210-4

Table 1.

Genetic association of genetic markers in SORL1 with dementia/AD risk and quantitative traits

Marker Group Genotypes dementia AD only AB42 p Tau p
AA AG GG

rs668387 cases 279 (219) 723 (572) 423 (353) 0.97(0.87–1.07) 0.95(0.86–1.06) 0.36 (639) 0.76 (655)
controls 444 1008 595 p = 0.50 p = 0.35

AA AG GG

rs689021 cases 274 (213) 762 (606) 459 (383) 0.97(0.88–1.07) 0.96(0.87–1.06) 0.52 (674) 0.75 (691)
controls 437 1051 649 p = 0.59 p = 0.39

AA AG GG

rs641120 cases 282 (221) 780 (624) 471 (393) 0.97(0.88–1.07) 0.96(0.87–1.06) 0.45 (704) 0.75 (721)
controls 448 1070 666 p = 0.55 p = 0.36

AA AC CC

rs2070045 cases 839 (677) 593 (480) 101 (80) 0.99(0.88–1.10) 0.96(0.86–1.08) 0.57 (705) 0.77 (722)
controls 1198 841 142 p = 0.82 p = 0.52

AA AT TT

rs3824968 cases 159 (134) 702 (559) 666 (538) 1.04(0.94–1.15) 1.08(0.97–1.19) 0.77 (700) 0.41 (717)
controls 229 967 988 p = 0.43 p = 0.16

AA AG GG

rs2282649 cases 147 (123) 687 (554) 693 (554) 1.06(0.95–1.17) 1.10(0.99–1.22) 0.80 (702) 0.43 (719)
controls 214 924 1040 p = 0.30 p = 0.078

Genotype counts are shown for dementia and (AD alone). Odds ratios (95% CI) and significances for case-control association in dementia and AD were determined using alternating logistic regression to account for sibling structure (as described in the main text). Significance for quantitative traits (number of individuals) was performed using ANOVA in unrelated individuals.